Dispensing Evaluation of Investigational Contact Lenses
1 other identifier
interventional
177
1 country
12
Brief Summary
Non-randomized, single-masked, 2-visit, bilateral wear, single-arm dispensing study to evaluate the visual acuity, rotational performance, lens fit, stability and subjective characteristics of a senofilcon-based JJVCI investigational toric contact lens design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2015
Shorter than P25 for not_applicable
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 3, 2015
CompletedFirst Posted
Study publicly available on registry
December 9, 2015
CompletedResults Posted
Study results publicly available
June 7, 2017
CompletedJune 7, 2017
May 1, 2017
1 month
November 3, 2015
August 11, 2016
May 5, 2017
Conditions
Outcome Measures
Primary Outcomes (4)
Proportion of Eyes With Monocular Visual Acuity Better Than 20/40
Monocular visual acuity was assessed using distance Snellen visual acuity. Visual Acuity data was dichotomized such that 'response=1' if a subjects has 20/40 or better and 'response=0' if subject has worse than 20/40. The proportion of eyes with 20/40 or better was reported.
7 day follow-up
The Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees
Absolute rotation was measured using a slit lamp. Absolute rotation measured at 15-minute post insertion was categorized into a binary outcome as 'response=1' if the absolute rotation is less than or equal to 10 degrees or 'response=0' otherwise. The proportion of eyes with absolute rotation less than or equal to 10 degrees was reported.
15 Minutes Post Insertion
Proportion of Subjects Eyes With Lens Stability With Blink Within 5 Degrees
Lens stability with blink was measured using a slit lamp. The rotational stability of the lens during a series of normal (unforced) blinks was measured for both eyes. The data was dichotomized as 'response=1' if the lens stability was less than or equal to 5 degrees or 'response=0' otherwise. The proportion of eyes with rotational stability of 5 degrees or lower was reported.
15 Minutes Post Insertion
Proportion of Subject Eyes With Acceptable Lens Fit
Acceptability of contact lens fit was assessed via slit lamp and was reported as a binary response as Acceptable or Unacceptable. The proportion of eyes with acceptable fit was reported.
15 Minute Post Insertion
Study Arms (1)
Prototype toric lens senofilcon A
EXPERIMENTALSubjects will wear the senofilcon A prototype toric contact lens bilaterally for 6-8 days as a daily disposable modality.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy adult males or females that are ≥18 years of age and ≤39 years of age.
- The subject must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must be a habitual toric contact lens wearer. Habitual wearer is defined as someone who wears toric lenses for at least 6 hours a day, 5 days a week for the past 30 days.
- Subject's vertex corrected spherical component of their distance refraction must be between -1.50 Diopters Sphere (DS) to -4.00 DS (inclusive) in each eye.
- Subject's vertex corrected refractive cylinder must be between -0.75 and -1.50 Diopters Cylinder (DC) (inclusive) in each eye.
- Subject's refractive cylinder axis must be within 180±15° and 90±15° in each eye.
- If needed, the subject must have a wearable pair of spectacles with 20/30 or better vision Ocular Uterque (OU). If spectacles are not needed, the subject must have 20/40 or better vision OU without correction.
- Subject's best corrected distance acuity must be 20/25-2 or better in each eye.
You may not qualify if:
- Females who are currently pregnant or lactating.
- Any ocular or systemic allergies or diseases that may contraindicate contact lens wear.
- Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, recurrent herpes simplex/zoster, Sjogren's syndromes, xerophthalmia, acne rosacea, and/or Stevens-Johnson syndromes, by self-report.
- Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV), by self-report.
- Habitual wearer of extended wear contact lenses.
- Any previous history of ocular and/or refractive surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.)
- History of seizures.
- Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by report.
- History of binocular vision abnormality or strabismus, by self-report.
- Habitual wearer of rigid gas permeable (RGP) lenses, orthokeratology lenses, or hybrid lenses (e.g. SynergEyes, SoftPerm) within the past 6 months.
- Employee and family members of employee of investigational clinic (e.g., Investigator, Coordinator, Technician).
- Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
- Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization, corneal staining, tarsal abnormalities, and conjunctival injection) on the FDA classification scale.
- Any history of a contact lens-related corneal inflammatory event within the past year that may contraindicate contact lens wear.
- Any active ocular infection.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Edward S. Wygonik, OD
Jacksonville, Florida, 32250, United States
The Eye Center
Pembroke Pines, Florida, 33024, United States
Eye Associates of Winter Park
Winter Park, Florida, 32792, United States
Eyecare Associates
Bloomington, Illinois, 61701, United States
Indiana University College of Optometry
Bloomington, Indiana, 47405, United States
Kannarr Eye Care
Pittsburg, Kansas, 66762, United States
ABQ Eyecare
Albuquerque, New Mexico, 87109, United States
Sacco Eye Group
Vestal, New York, 13850, United States
New Image Eye Center
Springfield, Ohio, 45503, United States
Professional Vision Care
Westerville, Ohio, 43081, United States
West Bay Eye Associates
Warwick, Rhode Island, 02888, United States
Total Eye Care PA
Memphis, Tennessee, 38119, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist
- Organization
- Johnson & Johnson Vision Care Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2015
First Posted
December 9, 2015
Study Start
October 1, 2015
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
June 7, 2017
Results First Posted
June 7, 2017
Record last verified: 2017-05